21.01.2015 Views

eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi

eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi

eur op eanexhibitionofcreati vityandinnovation - Europe Direct Iasi

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

EUROINVENT 2013<br />

24.2<br />

Title EN<br />

Authors<br />

Institution<br />

Patent no.<br />

Description<br />

EN<br />

Class no.<br />

Biotechnological proceeding to get fungal biomass of<br />

Lentinula edodes with immunomodulatory, antitumoral<br />

and antiinfection pr<strong>op</strong>erties<br />

Marian Petre<br />

University of Pitesti<br />

RO121678/2008<br />

The invention refers to the biotechnology of submerged cultivation<br />

of Lentinula edodes mushroom species by using a natural nutritive<br />

culture medium in order to get the fungal biomass having<br />

immunomodulatory, antitumoral and antiinfection pr<strong>op</strong>erties.<br />

The fungal biomass with immunomodulatory, antitumor and<br />

infectious pr<strong>op</strong>erties is produced by in vitro cultivation of<br />

mushroom species Lentinula edodes, in a liquid nutrient medium,<br />

consisting of the following natural ingredients: rice bran at a rate of<br />

10 ... 15% rye seed, shelled, germinated for 24 ... 48 h and then<br />

ground very fine 15 ... 20%, soy peptone 5 ... 10%, yeast extract 1<br />

... 5% deionized water the appr<strong>op</strong>riate volume to achieve 100%<br />

total percentage of the final solution based on the equivalent<br />

volume-weight ratio.<br />

The invention presents the following specific advantages:<br />

- the significant reduction of the period of necessary time to acquire<br />

the fungal biomass comparing to another cultivation methods that<br />

are already known;<br />

- the concentration increasing of the active biological compounds,<br />

particularly of β-glucans by using a nutritive media of very specific<br />

culture for this kind of eatable mushrooms which has<br />

pharmaceutical remarkable qualities.<br />

The mycelia biomass produced through this biotechnological<br />

proceeding contains active biological compounds, such as ex<strong>op</strong>olysaccharides,<br />

respectively, β-glucans and, also glycol-proteins<br />

and ergosterols. This biomass can be used for food supplements<br />

producing having the pr<strong>op</strong>erty to modulate the human immunity of<br />

organism and heal tumors and infections.<br />

3. Agriculture and Food Industry<br />

Image/<br />

Photo<br />

NATIONAL<br />

176

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!